Author

Wen G Jiang

Professor, Cardiff University School of Medicine - Cited by 33,900 - cancer - metastasis - invasion - angiogenesis - surgery

Biography

He have a long-standing interest in cancer metastasis and from 1987,his research interest has been on the molecular and cellular basis of cancer invasion and metastasis and therapeutic aspects of targeting cancer metastasis. he has been particularly interested in the bone, peritoneal and brain metastasis from primary tumours including breast, prostate, lung, GI cancers. his research has been conducted in Cardiff's School of Medicine and I have collaborated widely with colleagues in the UK, China, Europe, North America and Asia.
Title
Cited by
Year
Targeting hyaluronic acid and peritoneal dissemination in colorectal cancer
F Soliman, L Ye, W Jiang, R HargestClinical Colorectal Cancer 21 (2), e12-e134, 2022202
6
2022
Deregulated molecules and pathways in the predisposition and dissemination of breast cancer cells to bone
L Sui, A Sanders, WG Jiang, L YeComputational and Structural Biotechnology Journal 20, 2745-2758, 2022202
6
2022
Overexpressed transient receptor potential vanilloid 1 (TRPV1) in lung adenocarcinoma harbours a new opportunity for therapeutic targeting
Y Nie, F Feng, W Luo, AJ Sanders, Y Zhang, J Liang, C Chen, W Feng, ...Cancer gene therapy 29 (10), 140-1417, 2022202
5
2022
Activated leukocyte cell adhesion molecule (ALCAM), a potential ‘seed’and ‘soil’receptor in the peritoneal metastasis of gastrointestinal cancers
YM Yang, L Ye, F Ruge, Z Fang, K Ji, AJ Sanders, S Jia, C Hao, QP Dou, ...International Journal of Molecular Sciences 24 (1), 876, 20220
3
2023
Osteopontin and cancer: insights into its role in drug resistance
C Hao, J Lane, WG JiangBiomedicines 11 (1), 197, 030
2
2023
Death associated protein‑3 (DAP3) and DAP3 binding cell death enhancer‑1 (DELE1) in human colorectal cancer, and their impacts on clinical outcome and chemoresistance
L Sui, J Zeng, H Zhao, L Ye, TA Martin, AJ Sanders, F Ruge, A Jiang, ...International Journal of Oncology 6 (1), 1-16, 030
2
2023
EPLIN, a putative tumour suppressor in colorectal cancer, implications in drug resistance
J Zeng, AJ Sanders, L Ye, R Hargest, F Ruge, WG JiangInternational Journal of Molecular Sciences 3 (3), 153, 0
2
2022
ALCAM, activated leukocyte cell adhesion molecule, in clinical gastric cancer and patient’s response to chemotherapies
YM Yang, F Ruge, K Ji, S Jia, Y Jia, AJ Sanders, J Ji, WG JiangAnticancer research 43 (4), 463-475, 2023202
1
2023
Sex hormone-regulated CMG2 is involved in breast and prostate cancer progression
Z Fang, C Killick, C Halfpenny, N Frewer, KA Frewer, F Ruge, WG Jiang, ...Cancer Genomics & Proteomics 9 (6), 703-70, 2022202
1
2022
Breast Tumour Kinase (Brk/PTK6) contributes to breast tumour xenograft growth and modulates chemotherapeutic responses in vitro
RS Burmi, GM Box, U Wazir, HA Hussain, JA Davies, WJ Court, SA Eccles, ...Genes 3 (3), 402, 2022202
1
2022